James J. Vaughn, Chief Commercial Officer at GENOMIC HEALTH INC (GHDX), sold 1,497 shares at $32.50 ($49K) on 2018-05-02, disclosed to the SEC on 2018-05-04.
Scheduled sale ($49k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| GHDX | SELL | 2019-08-12 | $332K | — | Filing → |
| GHDX | SELL | 2019-07-09 | $399K | — | Filing → |
| GHDX | SELL | 2019-06-10 | $61K | — | Filing → |